Desmoid tumours (DES), a locally aggressive soft tissue neoplasm that lacks metastatic potential and harbours CTNNB1 mutations have also been included in the cohort. The gene discussed is CTNNB1; the disease is cerebellar ataxia, intellectual disability, and dysequilibrium.